FLORetina | VEGF Inhibitors From Macular Edema to Diabetic Retinopathy | 21.09.21

VEGF Inhibitors From Macular Edema to Diabetic Retinopathy

21 September 2021
6:30 PM, CEST

vegf inhibitors webinar 2021

vegf inhibitors webinar 2021

vegf inhibitors webinar 2021

Stanislao Rizzo
Federico Ricci

Pathophysiology of diabetic retinopathy: the role of vascular growth factor
Federico Ricci

Evidence that DME sustained treatment with VEGF inhibitors improves severity and progression of diabetic retinopathy
Alessandro Invernizzi
Pros: Angelo Minnella
Cons: Massimo Nicolò

VEGF inhibitors in non-proliferative diabetic retinopathy as prevention of sight-threatening complications
Marco Lupidi
Pros: Edoardo Midena
Cons: Monica Varano

Pharmacological treatment of proliferative diabetic retinopathy in 2021
Francesco Viola
Pros: Giovanni Staurenghi
Cons: Francesco Bandello

Role of pharmacological therapy of vitreous hemorrhage from PDR after Protocol AB
Daniele Veritti
Pros: Paolo Lanzetta
Cons: Francesco Boscia

Closing remarks
Stanislao Rizzo


Related Posts

Revolutionizing Eye Health: Emerging Technologies and Treatments for Optimal Vision

In the ever-evolving landscape of eye health, groundbreaking technologies and innovative treatments are reshaping the...

TEN 02.03.2023 Monthly News

7. Treatment for Diabetic Retinopathy. Diabetic retinopathy is known to affect your eyes with different...

TEN 01.02.2023 Monthly News

7. PRK: Refractive Eye Surgery. Photorefractive Keratectomy (PRK) was the first laser refractive eye surgery...